Ryvu Therapeutics S.A. announced a private placement of up to 4,800,000 series J shares to be issued at a price of PLN 0.395833 per share for proceeds of up to PLN 1,900,000 on October 6, 2022. The transaction has been approved by the management board. The securities are subject to a hold period of 12 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.6 PLN | -1.82% | -1.42% | -15.48% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.48% | 280M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- RVU Stock
- News Ryvu Therapeutics S.A.
- Ryvu Therapeutics S.A. announced that it expects to receive PLN 1.899998 million in funding